160462-33-9

Upstream product

• 35750-24-4 methyl 4-allyloxybenzoate 
• 151954-45-9 α-<(trimethylsilyl)oxy>-3-methylphenylacetonitrile 
• 620-23-5 m-tolyl aldehyde 
• 153275-16-2 (3,5-dipropyl-4-hydroxy)benzyl alcohol 
• 137445-54-6 methyl 4-tert-butyldimethyl-silyloxy-3,5-dipropylbenzoate 
• 137421-54-6 methyl 4-tert-butyldimethylsilyloxy-3,5-di(2-propen-1-yl)benzoate 
• 137421-55-7 t-butyl-dimethylsilyloxy-2,6-dipropyl-4-hydroxymethyl benzene 
• 137421-52-4 methyl 3-(2-propenyl)-4-(2-propenyloxy)benzoate 
• 137421-53-5 methyl 3,5-diallyl-4-hydroxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 62281-73-6 ethyl α-hydroxy-3-methylphenylacetate 
• 53596-60-4 methyl 3-allyl-4-hydroxybenzoate 
• 37051-40-4 ethyl α-bromo-3-methylphenylacetate 

Downstream Products

• 153275-21-9 [4-(2-Ethyl-5,7-dimethyl-imidazo[4,5-b]pyridin-3-ylmethyl)-2,6-dipropyl-phenoxy]-m-tolyl-acetic acid ethyl ester 
• 160462-34-0 ethyl 2-(2,6-Dipropyl-4-Bromomethyl-Phenoxy)-2-(3-Methylphenyl)Acetate 

Relevant academic research and scientific papers

BENZIMIDAZOLINONES SUBSTITUTED WITH PHENOXYPHENYLACETIC ACID DERIVATIVES

Phenoxyphenylacetic acids and derivatives of the general structural formula I STR1 have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, pulmonary hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, inflammatory diseases including Raynaud's disease and asthma.

QUINAZOLINONES SUBSTITUTED WITH PHENOXYPHENYLACETIC ACID DERIVATIVES

Phenoxyphenylacetic acids and derivatives of general structural formula I STR1 have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebral and car